Table 2 Antipsychotic preferences for different disorders at discharge (n = 981)
| Â | Total | MDD | AD | DCR | OMD | MDPS | Dementia | SMD | OCD | Insomnia | BEDO | Other |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
N = 981 | N = 391 | N = 121 | N = 99 | N = 93 | N = 73 | N = 62 | N = 19 | N = 18 | N = 16 | N = 14 | N = 75 | |
Olanzapine | 29.1% | 23.8%a | 15.7% | 55.6% | 44.1% | 30.1% | 27.4% | 42.1% | 5.6% | 12.5% | 14.3% | 33.3% |
Quetiapine | 20.3% | 19.9%b | 17.4% | 21.2% | 18.3% | 23.3% | 38.7% | 15.8% | 11.1% | 12.5% | 21.4% | 14.7% |
Risperidone | 6.8% | 2.0% | – | 11.1% | 15.1% | 13.7% | 14.5% | 5.3% | 5.6% | – | 14.3% | 14.7% |
Aripiprazole | 6.6% | 5.9%b | 2.5% | 5.1% | 5.4% | 4.1% | 1.6% | – | 55.6% | – | 42.9% | 12.0% |
Clozapine | 1.9% | 2.0% | 2.5% | 2.0% | 1.1% | 1.4% | 1.6% | – | – | – | 7.1% | 2.7% |
Other SGAs c | 3.2% | 2.3% | 0.8% | 7.1% | 5.4% | 5.5% | – | 5.3% | – | – | – | 5.3% |
FGAs d | 2.4% | 1.8% | 0.8% | 3.0% | 5.4% | 4.1% | 3.2% | 5.3% | – | – | – | 2.7% |